XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Description of Business and Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Aug. 22, 2022
Jul. 31, 2022
Jul. 31, 2021
Feb. 01, 2022
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Outstanding capital stock   51.00%    
Capital stock   41.00%    
Cash and cash equivalents (in Dollars)   $ 26,500    
Sale securities (in Dollars)   36,700    
Hedge fund investment (in Dollars)   4,800    
Restricted cash (in Dollars)   $ 5,000 $ 5,000
Bad debt expense (in Dollars)   4 193  
Amortized debt issuance costs (in Dollars)   $ 472 $ 28  
Tax benefit, percentage   50.00%    
CS Pharma Holdings, LLC [Member]        
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Percentage owned   50.00%    
Interest percentage   45.00%    
Pharma Holdings, LLC [Member]        
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Percentage owned   90.00%    
Credit risk [Member]        
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Concentrations risk percentage   58.00% 65.00%  
Subsequent Event [Member]        
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Net proceeds (in Dollars) $ 33,000      
Property purchase (in Dollars) $ 49,400      
Related Party [Member]        
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Concentrations risk percentage   58.00% 65.00%  
Accounts Receivable [Member] | One Customers [Member]        
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Concentrations risk percentage   24.00% 45.00%  
Accounts Receivable [Member] | Two Customers [Member]        
Description of Business and Summary of Significant Accounting Policies (Details) [Line Items]        
Concentrations risk percentage   47.00% 33.00%